http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014201104-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4063f6f4642d9b540ecbfa1d10715eba
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
filingDate 2014-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e6ce09225b37612cb70a45852b2f6ef
publicationDate 2015-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014201104-A3
titleOfInvention Methods and kits for treating and classifying individuals
abstract The present disclosure provides methods and kits for treating and classifying individuals at risk of or suffering from a neurological and/or mitochondrial dysfunction or disorder. In general, the individuals are treated and/or classified based on the presence of a loss-of-function mutation in nuclear DNA encoding one or more proteins selected from the group consisting of ALDH1L1, ALDH1L2, FOLR1, FPGS, GCSH, GLDC, MTHFD1, MTHFD1L, MTHFD2, MTHFD2L, MTHFS, MTRR, SHMT1, SHMT2 and SLC25A32. Treatment involves the administration of a therapeutically effective amount of folinic acid, glycine or a pharmaceutically acceptable salt thereof.
priorityDate 2013-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0200863-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012135402-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011109440-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02052044-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136123990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135402009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422204

Total number of triples: 27.